Alcohol consumption and plasma concentration of C-reactive protein - PubMed (original) (raw)

Clinical Trial

Alcohol consumption and plasma concentration of C-reactive protein

Michelle A Albert et al. Circulation. 2003.

Abstract

Background: Moderate alcohol intake has been associated with lower cardiovascular mortality. However, data evaluating the relationship between C-reactive protein (CRP), a predictor of cardiovascular risk, and alcohol consumption are sparse.

Methods and results: The relationship between alcohol consumption and CRP was evaluated in a cross-sectional survey and over time among 1732 men and 1101 women participating in the Pravastatin Inflammation/CRP Evaluation Study. CRP levels were lower in those with moderate alcohol intake versus light or occasional intake: in 5 categories of alcohol intake (no alcohol or <1 drink monthly, 1 to 3 drinks monthly, 1 to 4 drinks weekly, 5 to 7 drinks weekly, and > or =2 drinks daily), median CRP levels were 2.60 mg/L (interquartile range (IQR), 1.20 to 5.30 mg/L), 2.20 mg/L (IQR, 1.00 to 4.40 mg/L), 1.70 mg/L (IQR, 0.80 to 3.80 mg/L), 1.60 mg/L (IQR, 0.80 to 3.30 mg/L), and 1.80 mg/L (IQR, 0.80 to 2.90 mg/L), respectively. This relationship was present among men, women not taking hormone replacement therapy, nonsmokers, and those individuals with and without a history of cardiovascular disease (all P<0.001). In multivariate analysis, the relationship between alcohol consumption and CRP remained significant after controlling for multiple traditional cardiovascular risk factors. Alcohol consumption did not significantly affect the change in CRP or lipid levels associated with statin use.

Conclusion: Moderate alcohol consumption was associated with lower CRP concentrations than no or occasional alcohol intake, an effect that was independent of alcohol-related effects on lipids. Alcohol may attenuate cardiovascular mortality in part through an anti-inflammatory mechanism.

PubMed Disclaimer

Cited by

Vague relationship between alcohol consumption and metabolic syndrome in nonobese people.
Nakajima K, Saito M. Nakajima K, et al. World J Gastroenterol. 2012 Oct 7;18(37):5315-6. doi: 10.3748/wjg.v18.i37.5315. World J Gastroenterol. 2012. PMID: 23066331 Free PMC article.
Psychological distress and C-reactive protein: do health behaviours and pathophysiological factors modify the association?
Puustinen PJ, Koponen H, Kautiainen H, Mäntyselkä P, Vanhala M. Puustinen PJ, et al. Eur Arch Psychiatry Clin Neurosci. 2011 Jun;261(4):277-84. doi: 10.1007/s00406-010-0134-x. Epub 2010 Aug 14. Eur Arch Psychiatry Clin Neurosci. 2011. PMID: 20711599
Risk Factors of Cardiovascular Disease according to Alcohol Behavioral Change after Cancer Diagnosis.
Bae EM, Cho IY, Jun JH, Lee K, Kim JY, Bae WK, Lee H, Han JS, Jung SY, Lee KH, Kim S, Koo HY, Cho SJ, Lee H, Paek C. Bae EM, et al. Korean J Fam Med. 2020 Jul;41(4):222-228. doi: 10.4082/kjfm.18.0119. Epub 2020 Apr 22. Korean J Fam Med. 2020. PMID: 32316706 Free PMC article.
Moderate use of alcohol is associated with lower levels of C reactive protein but not with less severe joint inflammation: a cross-sectional study in early RA and healthy volunteers.
Mangnus L, van Steenbergen HW, Nieuwenhuis WP, Reijnierse M, van der Helm-van Mil AHM. Mangnus L, et al. RMD Open. 2018 Jan 7;4(1):e000577. doi: 10.1136/rmdopen-2017-000577. eCollection 2018. RMD Open. 2018. PMID: 29479472 Free PMC article.
Testing for non-linear causal effects using a binary genotype in a Mendelian randomization study: application to alcohol and cardiovascular traits.
Silverwood RJ, Holmes MV, Dale CE, Lawlor DA, Whittaker JC, Smith GD, Leon DA, Palmer T, Keating BJ, Zuccolo L, Casas JP, Dudbridge F; Alcohol-ADH1B Consortium. Silverwood RJ, et al. Int J Epidemiol. 2014 Dec;43(6):1781-90. doi: 10.1093/ije/dyu187. Epub 2014 Sep 5. Int J Epidemiol. 2014. PMID: 25192829 Free PMC article.

Alcohol consumption and plasma concentration of C-reactive protein - PubMed (original) (raw)